
ASHP is the largest association of pharmacy professionals in the United States, representing over 65,000 pharmacists, student pharmacists, and pharmacy technicians in all patient care settings, including hospitals, ambulatory clinics, and health-system community pharmacies. For over 80 years, ASHP has championed innovation in pharmacy practice, advanced education and professional development, and served as a steadfast advocate for members and patients. In addition, ASHP is an accrediting body for pharmacy residency and technician training programs, and provides comprehensive resources to support pharmacy professionals through every stage of their careers.
ASHP is the largest association of pharmacy professionals in the United States, representing over 65,000 pharmacists, student pharmacists, and pharmacy technicians in all patient care settings, including hospitals, ambulatory clinics, and health-system community pharmacies. For over 80 years, ASHP has championed innovation in pharmacy practice, advanced education and professional development, and served as a steadfast advocate for members and patients. In addition, ASHP is an accrediting body for pharmacy residency and technician training programs, and provides comprehensive resources to support pharmacy professionals through every stage of their careers.
Episodes

Tuesday May 12, 2026
Clinical Conversations: CE: Recorded Pharmacist Series: DKA
Tuesday May 12, 2026
Tuesday May 12, 2026
This episode will review the management of diabetic ketoacidosis (DKA), hyperosmolar hyperglycemic state (HHS) and euglycemic diabetic ketoacidosis (eDKA). Listeners will review the most current DKA/HHS guidelines and will be able to effective identify patients receiving insulin and fluid therapy that require changes in treatment to improve safety and disease resolution.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Tuesday May 12, 2026
Advocating for Impact: Doses and Dollars: The Latest on New Drug Pricing Models
Tuesday May 12, 2026
Tuesday May 12, 2026
This podcast explores how the federal government is attempting to lower prescription drug prices by examining the newest most-favored nation-focused drug pricing models, including TrumpRx and the GLOBE and GUARD mandatory models. We discuss how each model is structured and its potential impacts on patients, the healthcare system, and the pharmacy workforce.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Monday May 11, 2026
Monday May 11, 2026
In this episode, Megan Musselman sits down with the Section of Clinical Specialists and Scientists Distinguished Service Awardee Martha Roberts to discuss what membership within the section and ASHP means to them and how it has helped develop them into a pharmacy practice leader.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Friday May 08, 2026
Clinical Conversations: CE: Recorded Pharmacist Series: Status Epilepticus
Friday May 08, 2026
Friday May 08, 2026
This episode series will focus on the identification and underlying etiologies of status epilepticus, review treatment recommendations, and compare available antiepileptic agents for the management of status epilepticus. CE for this episode expires 2 years after the date it was originally published.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Friday May 08, 2026
Friday May 08, 2026
In this episode, Jeff Chalmers, immediate past-chair of the ASHP Section of Pharmacy Informatics and Technology, has a discussion with Distinguished Service Awardee for 2025, Darren Ferer, to discuss his service within the section and the role ASHP has played in his development as a pharmacy practice leader.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Tuesday May 05, 2026
Insights & Connections: Shaping Pharmacy’s Future
Tuesday May 05, 2026
Tuesday May 05, 2026
Insights & Connections: Shaping Pharmacy’s Future is an ASHP podcast series that brings people, perspectives, and ideas together to shape the future of pharmacy practice.
Through conversations with ASHP Executive Vice President & CEO Sam Calabrese and voices spanning the profession, each episode highlights the insights that emerge through connection and collaboration—and how shared perspectives are helping move pharmacy forward.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Saturday May 02, 2026
Clinical Conversations: CE: Vaccine Preventable Diseases: Measles Revisited (CE)
Saturday May 02, 2026
Saturday May 02, 2026
There have been several reported measles outbreaks within the US with increasing frequency over the last decade. Recent changes to the CDC/ACIP further add to concern regarding the MMR vaccine and potential future illnesses.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Friday May 01, 2026
Friday May 01, 2026
This podcast highlights how the University of Rhode Island’s College of Pharmacy SSHP created and hosted a series of clinical pharmacist and alumni panels to help students explore a wide range of pharmacy career pathways. The conversation showcases the chapter’s goals, planning approach, and the value these events provided to student pharmacists.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Wednesday Apr 29, 2026
Hot Topics in Pharmacy: ASHP Advantage: Sourcing the Vaccine Resources
Wednesday Apr 29, 2026
Wednesday Apr 29, 2026
Experts shed light on the latest updates in pneumococcal disease and vaccinations, including updated guideline recommendations, how to apply them to different patient populations, and innovations to increase pharmacist administration of vaccines and associated patient education.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Tuesday Apr 28, 2026
Tuesday Apr 28, 2026
In this episode, we look at how pharmacy compliance intersects with drug diversion. Hear expert insights, real-world examples, and practical strategies to protect your practice and your patients.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
